申请人:ChemoCentryx, Inc.
公开号:US20130172315A1
公开(公告)日:2013-07-04
Aniline compounds are provided which bind to CCR(4) and are useful for the treatment of diseases such as allergic diseases, autoimmune diseases, graft rejection and cancer.
提供了结合CCR(4)并用于治疗过敏性疾病、自身免疫性疾病、移植排斥和癌症等疾病的苯胺化合物。